NCT04054219 is a NA clinical trial of Bone graft substitute in Bone Loss in Jaw, sponsored by Wishbone SA.

Who is sponsoring NCT04054219?

NCT04054219 is sponsored by Wishbone SA.

What drugs are being tested in NCT04054219?

Interventions in NCT04054219: Bone graft substitute.

What condition does NCT04054219 study?

NCT04054219 studies Bone Loss in Jaw.

Is NCT04054219 still recruiting?

NCT04054219 is currently status unknown. Last updated 21 August 2019.

Last reviewed 2019-08-21 · How we verify

NCT04054219

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Efficacy and Safety of Wishbone HA as Bone Graft Substitute, a Pre-market Clinical Investigation

Status unknown NA Last updated 21 August 2019

What this trial tests

NA trial testing Bone graft substitute in Bone Loss in Jaw in 47 participants. Status unknown.

Timeline

8 July 2019

Primary endpoint
28 February 2020

31 May 2021

Quick facts

Lead sponsor	Wishbone SA
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	47
Start date	8 July 2019
Primary completion	28 February 2020
Estimated completion	31 May 2021
Sites	1 location across Belgium

Drugs / interventions tested

Bone graft substitute

Conditions studied

Bone Loss in Jaw — all drugs for Bone Loss in Jaw →

Sponsor

Wishbone SA

Who can join

Adults 18 to 80, any sex, with Bone Loss in Jaw. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of efficacy and safety of Wishbone HA as bone graft substitute, a pre-market clinical investigation. Group1: Extraction Socket management Group 2: Sinus lift

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Bone graft substitute

Trials testing the same drug.

NCT04644536 — Retrospective Collection of Safety and Performance Data · terminated

Other recruiting trials for Bone Loss in Jaw

Currently open trials in the same condition.

NCT07102758 — L-PRF vs Connective Tissue With Customized Healing Abutment in Immediate Implant Placement · NA · recruiting
NCT07137533 — Mandibular Overdentures vs All-on-4 With PEEK · recruiting

Other Wishbone SA trials

Trials by the same sponsor.

NCT06383377 — Evaluation of Performance, Safety and Benefit of the Wishbone HA as Bone Graft Substitute, a Pre-market Clinical Investi · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04054219 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wishbone SA
Last refreshed: 21 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04054219.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing